Content area
Abstract
The FDA has approved all-trans retinoic acid, a vitamin A derivative, for the treatment of acute promyelocytic leukemia. The drug is the first retinoid to be approved for cancer treatment in the US.
You might have access to more details...
Try and log in through your library or institution to see if they have access.
The FDA has approved all-trans retinoic acid, a vitamin A derivative, for the treatment of acute promyelocytic leukemia. The drug is the first retinoid to be approved for cancer treatment in the US.